QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-half of one redeemable warrant |
||||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ||||||
Table of Contents
| PART I. |
FINANCIAL INFORMATION | 1 | ||||
| Item 1. |
Financial Statements | 1 | ||||
| 1 | ||||||
| 2 | ||||||
| Unaudited Condensed Statement of Changes in Shareholders’ Deficit |
3 | |||||
| 4 | ||||||
| 5 | ||||||
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15 | ||||
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk | 18 | ||||
| Item 4. |
Controls and Procedures | 18 | ||||
| PART II. |
OTHER INFORMATION | 18 | ||||
| Item 1. |
Legal Proceedings | 18 | ||||
| Items 1A. |
Risk Factors | 18 | ||||
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds | 19 | ||||
| Item 3. |
Defaults upon Senior Securities | 19 | ||||
| Item 4. |
Mine Safety Disclosures | 19 | ||||
| Item 5. |
Other Information | 19 | ||||
| Item 6. |
Exhibits | 19 | ||||
PART I. |
FINANCIAL INFORMATION |
Item 1. |
Financial Statements |
As of March 31, 2023 (unaudited) |
As of December 31, 2022 |
|||||||
| Assets: |
||||||||
| Current assets: |
||||||||
| Cash |
$ | $ | ||||||
| Prepaid expenses and other current assets |
||||||||
| |
|
|
|
|||||
| Total current assets |
||||||||
| Restricted cash |
|
|
|
|
|
|
|
|
| Cash and investments held in Trust Account |
||||||||
| |
|
|
|
|||||
| Total assets |
$ | $ | ||||||
| |
|
|
|
|||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: |
||||||||
| Current liabilities: |
||||||||
| Accounts payable and accrued expenses |
$ | $ | ||||||
| Due to related parties |
||||||||
| Convertible promissory note - related party, at fair value |
||||||||
| |
|
|
|
|||||
| Total current liabilities |
||||||||
| Deferred underwriting fees payable |
||||||||
| Derivative warrant liability |
||||||||
| |
|
|
|
|||||
| Total liabilities |
||||||||
| |
|
|
|
|||||
| Commitments and Contingencies (Note 5) |
||||||||
| Common stock subject to possible redemption, |
||||||||
| Shareholders’ Deficit: |
||||||||
| Preferred stock, $ |
||||||||
| Class A ordinary shares, $ |
||||||||
| Class B ordinary shares, $ |
||||||||
| Additional paid-in capital |
||||||||
| Accumulated deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total shareholders’ deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
$ | $ | ||||||
| |
|
|
|
|||||
For the Three Months Ended March 31, 2023 |
For the Three Months Ended March 31, 2022 |
|||||||
| General and administrative expenses |
$ | $ | ||||||
| |
|
|
|
|||||
| Loss from Operations |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| Other income (expense): |
||||||||
| Change in fair value of derivative warrant liabilities |
( |
) | ||||||
| Change in fair value of convertible promissory note – related party |
||||||||
| Income earned in marketable securities held in Trust Account |
||||||||
| |
|
|
|
|||||
| Total other income, net |
||||||||
| |
|
|
|
|||||
| Net income |
$ | $ | ||||||
| |
|
|
|
|||||
| Basic and diluted weighted average shares outstanding, Class A |
||||||||
| |
|
|
|
|||||
| Basic and diluted net income per share, Class A |
$ | $ | ||||||
| |
|
|
|
|||||
| Basic and diluted weighted average shares outstanding, Class B |
||||||||
| |
|
|
|
|||||
| Basic and diluted net income per share, Class B |
$ | $ | ||||||
| |
|
|
|
|||||
Ordinary Shares |
Additional Paid- |
Accumulated |
Total Shareholders’ |
|||||||||||||||||
Shares |
Amount |
In Capital |
Deficit |
Deficit |
||||||||||||||||
| Balance as of December 31, 2022 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| Stock-based compensation |
— | — | — | |||||||||||||||||
| Proceeds received in excess of initial fair value of convertible promissory note |
— | — | — | |||||||||||||||||
| Remeasurement of Class A ordinary shares subject to possible redemption value |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||
| Net Income |
— | — | — | |||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of March 31, 2023 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
Ordinary Shares |
Additional Paid- |
Accumulated |
Total Shareholders’ |
|||||||||||||||||
Shares |
Amount |
In Capital |
Deficit |
Deficit |
||||||||||||||||
| Balance as of December 31, 2021 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| Stock-based compensation |
— | — | — | |||||||||||||||||
| Net Income |
— | — | — | |||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of March 31, 2022 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
For the Three Months Ended March 31, 2023 |
For the Three Months Ended March 31, 2022 |
|||||||
| Cash flows used in operating activities: |
||||||||
| Net income |
$ | $ | ||||||
| Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
| Stock-based compensation |
||||||||
| Unrealized change in fair value of warrant liabilities |
( |
) | ||||||
| Unrealized change in fair value of convertible promissory note – related party |
( |
) | — | |||||
| Income earned in marketable securities held in Trust Account |
( |
) | ( |
) | ||||
| Bank service fees |
— | |||||||
| Changes in operating assets and liabilities: |
||||||||
| Other Current Assets |
( |
) | ||||||
| Accounts payable and accrued expenses |
( |
) | ||||||
| Non-Current Assets |
— | |||||||
| Due to related party |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash used in operating activities |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| Cash flows from investing activities: |
||||||||
| Cash deposited in Trust Account |
( |
) | — | |||||
| Cash withdrawn from Trust Account in connection with redemption |
— | |||||||
| Cash withdrawn from Trust Account for estimated tax obligation |
— | |||||||
| |
|
|
|
|||||
| Net cash provided by investing activities |
||||||||
| |
|
|
|
|||||
| Cash flows from financing activities: |
||||||||
| Redemption of Class A common stock |
( |
) | — | |||||
| Proceeds from convertible promissory note - related party |
||||||||
| Repayments of loans from related parties |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash used in financing activities |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| Net change in cash and restricted cash |
( |
) | ||||||
| Cash and restricted cash beginning of period |
||||||||
| |
|
|
|
|||||
| Cash and restricted cash end of period |
$ |
$ |
||||||
| |
|
|
|
|||||
| Supplemental disclosure with respect to cash flows: |
||||||||
| Change in value of Class A ordinary shares subject to possible redemption |
$ | $ | ||||||
| |
|
|
|
|||||
| Proceeds received in excess of initial fair value of convertible promissory note |
$ | $ | ||||||
| |
|
|
|
|||||
| Class A ordinary shares subject to possible redemption as of December 31, 2021 |
$ | |||
| Remeasurement of Class A ordinary shares subject to possible redemption to redemption value |
||||
| |
|
|||
| Class A ordinary shares subject to possible redemption as of December 31, 2022 |
||||
| Redemptions |
( |
) | ||
| Remeasurement of Class A ordinary shares subject to possible redemption to redemption value |
||||
| |
|
|||
| Class A ordinary shares subject to possible redemption as of March 31, 2023 |
$ | |||
| |
|
|
|
|
For the Three Months Ended March 31, 2023 |
For the Three Months Ended March 31, 2022 |
|||||||
| Class A ordinary shares |
||||||||
| Numerator: |
||||||||
| Allocation of net income |
$ | $ | ||||||
| Denominator: |
||||||||
| Basic and diluted weighted average shares outstanding |
||||||||
| |
|
|
|
|||||
| Basic and diluted earnings per share |
$ |
$ |
||||||
| |
|
|
|
|||||
| Class B ordinary shares |
||||||||
| Numerator: |
||||||||
| Allocation of net income |
$ | $ | ||||||
| Denominator: |
||||||||
| Basic and diluted Weighted Average shares outstanding |
||||||||
| |
|
|
|
|||||
| Basic and diluted earnings per share |
$ |
$ |
||||||
| |
|
|
|
|||||
| • | Level 1 – Observable inputs for identical assets or liabilities such as quoted prices in active markets; |
| • | Level 2 – Inputs other than quoted prices in active markets that are either directly or indirectly observable; and |
| • | Level 3 – Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use. |
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of |
| • | if, and only if the last reported sale price of Class A ordinary shares for any period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $a |
| • | in whole and not in part; |
| • | at a price of $ |
| • | if, and only if the Reference Value equals or exceeds $ |
| • | if, and only if the Reference Value is less than $ |
| Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
| Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. | |
March 31, |
December 31 |
|||||||||||
| Description |
Level |
2023 |
2022 |
|||||||||
| Assets: |
||||||||||||
| Cash and investments held in Trust Account |
1 | $ | |
$ | |
|||||||
| Liabilities: |
||||||||||||
| Warrant Liability – Public Warrants |
1 | $ | $ | |||||||||
| Warrant Liability – Private Placement Warrants |
3 | $ | $ | |||||||||
| Convertible promissory note– related party |
3 | $ | $ | |||||||||
| Input |
March 31, 2023 |
December 31, 2022 |
||||||
| Risk-free interest rate |
% | % | ||||||
| Expected term (years) |
||||||||
| Expected volatility |
% | % | ||||||
| Exercise price |
$ | $ | ||||||
| Unit Price (public) |
$ | $ | ||||||
| Unit Price (private) |
$ | $ | ||||||
Private Placement Warrant Liabilities |
||||
| Fair value as of December 31, 2022 |
$ | |||
| Change in fair value |
||||
| |
|
|||
| Fair value as of March 31, 2023 |
$ | |||
| |
|
|||
| Input |
March 31, 2023 |
February 3, 2023 |
||||||
| Risk-free interest rate |
% | % | ||||||
| Expected term (years) |
||||||||
| Expected volatility |
% | % | ||||||
| Exercise price |
$ | $ | ||||||
| Dividend yield |
% | % | ||||||
| Stock price |
$ | $ | ||||||
| Probability of transaction |
% | % | ||||||
Convertible Promissory Note |
||||
| Fair value as of January 1, 2023 |
$ | |||
| Proceeds received through Convertible Promissory Note |
||||
| Proceeds received in excess of initial fair value of convertible promissory note |
( |
) | ||
| Change in fair value |
( |
) | ||
| |
|
|||
| Fair value as of March 31, 2023 |
$ | |||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
References to “we”, “us”, “our” or the “Company” are to Talon 1 Acquisition Corp., except where the context requires otherwise. The following discussion should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this report.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.
Overview
We were incorporated as a Cayman Islands exempted company and incorporated with limited liability on April 20, 2021. The Company was incorporated for the purpose of effecting a merger capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses
On November 8, 2021, the Company consummated its initial public offering (the “
In connection with the Trust
The Sponsor may elect to convert up to $1,500,000 of the outstanding principal balance of the Note into warrants to purchase shares of Class A ordinary shares of the Company at a conversion price
The proceeds of the Note will be used by the Company to deposit additional funds to the Trust Account in connection with the extension of the amount of time the Company has available to complete a business combination and to fund the Company’s
In connection with the Extraordinary General Meeting, stockholders elected to redeem an aggregate of 13,317,392 Class A Ordinary Shares at a redemption price of approximately $10.41 per share (the “Redemption”), for an aggregate redemption amount of approximately $138,634,051.
If the Company is unable to complete our initial Business Combination within the
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities since April 20, 2021 (inception) have been organizational activities and those necessary to prepare for our initial public offering. We do not expect to generate any operating revenues until after completion of our initial Business Combination. We generate non-operating income in the form of interest income and unrealized gains on investments held in our Trust Account. Our expenses have increased substantially after the closing of our initial public offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expense related to the search for a prospective initial Business Combination.
For the three months ended
For the three months ended March 31, 2022, we had net income of $4,
Liquidity and Capital Resources
On November 8, 2021, we consummated our initial public offering of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $200,000,000. Simultaneously with the closing of our initial public offering, the underwriters fully exercised the over-allotment option, generating gross proceeds of $30,000,000.
Simultaneously with the closing of our initial public offering, the Company consummated the sale of 13,250,000 warrants at a price of $1.00 per Private Placement Warrant in a private placement to our Sponsor generating gross proceeds of $13,250,000.
A total of $235,750,000 of the proceeds from our initial public offering, a portion of the sale of the private placement warrants, the sale of the over-allotment units and the sale of the over-allotment warrants were placed in a U.S.-based
As of As of The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. As of As of
post Business Combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial Business Combination, we do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities as a result of this uncertainty.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
16
Net Income Per Ordinary Share
Net income per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. On
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815,
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2022 and it did not impact the Company’s financial position, results of operations, or cash flows.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
Off-Balance Sheet Arrangements
As of the date of this Quarterly Report on Form 10-Q, we did not have any off-balance sheet arrangements.
Commitments and Contractual Obligations
We do not have any long term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or other long term liabilities, other than an agreement to pay our Sponsor a monthly fee of $10,000 for office space and administrative support. We began incurring these fees on November 3, 2021 and will continue to incur these fees monthly until the earlier of the completion of the initial
Registration Rights
The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans), are entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that we will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate, payable upon the closing of the initial public offering. An additional fee of $0.35 per Unit, or $8,050,000 in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Investment Advisory Agreement
On January 20, 2023, the Company entered into an investment advisory agreement with Genaesis, LLC (“Genaesis”) pursuant to which Genaesis will serve as the non-exclusive transaction advisor in connection with the potential identification and introduction of candidates to the Company for a business combination, or financing or equity investment in the Company. In the event that the Company consummates such a transaction with a target introduced by Genaesis within 24 months of this agreement, it shall pay Genaesis a 1% “Success fee” of the capital committed by the Company for such transaction and Genaesis will be entitled to charge appropriate expenses for its services to the Company for placing an announcement and/or press release on their behalf.
17
JOBS Act
On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
As an “emerging growth company,” we are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose comparisons of the chief executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five (5) years following the completion of our initial public offering or until we otherwise no longer qualify as an “emerging growth company.”
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
We are a smaller reporting company as defined by Rule
| Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our
Changes in Internal Control over Financial Reporting
We have continued our remediation efforts in connection with the identification of the material weakness discussed above. Specifically, we have expanded and improved our closing process with respect to the review of the carrying value of the of Class A ordinary shares subject to redemption. As of
| PART II. |
|
| Item 1. | Legal Proceedings |
None.
| Items 1A. | Risk Factors |
As of the date of this Quarterly Report
18
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. |
None.
| Item 3. | Defaults |
None.
| Item 4. | Mine Safety Disclosures |
Not applicable.
| Item 5. | Other Information |
None.
| Item 6. | Exhibits |
| * | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated:
| By: | /s/ Edward J. Wegel | |
| Name: | Edward J. Wegel | |
| Title: | Chief Executive Officer (principal executive officer) |
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Edward J. Wegel, certify that:
1. I have reviewed this
Quarterly Report on Form 10-Q for the quarter ended
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
| By: | /s/ Edward J. Wegel | |||||||
| Edward J. Wegel | ||||||||
| Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Ryan Goepel, certify that:
1. I have reviewed this Quarterly
Report on Form 10-Q for the quarter ended
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
| /s/ Ryan Goepel | ||||||||
| Ryan Goepel | ||||||||
| Chief Financial Officer | ||||||||
| (Principal Financial and Accounting Officer) | ||||||||
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Talon 1 Acquisition Corp. (the Company) on Form 10-Q for the
quarter ended
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| By: | /s/ Edward J. Wegel | |||||||
| Edward J. Wegel | ||||||||
| Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Talon 1 Acquisition Corp. (the Company) on Form 10-Q for the
quarter ended
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| By: | /s/ Ryan Goepel | |||||||
| Ryan Goepel | ||||||||
| Chief Financial Officer | ||||||||
| (Principal Financial and Accounting | ||||||||